Cargando…
4-Phenyl-1,3-thiazole-2-amines as scaffolds for new antileishmanial agents
BACKGROUND: There is still a need for new alternatives in pharmacological therapy for neglected diseases, as the drugs available show high toxicity and parenteral administration. That is the case for the treatment of leishmaniasis, particularly to the cutaneous clinical form of the disease. In this...
Autores principales: | Rodrigues, Carina Agostinho, dos Santos, Paloma Freire, da Costa, Marcela Oliveira Legramanti, Pavani, Thais Fernanda Amorim, Xander, Patrícia, Geraldo, Mariana Marques, Mengarda, Ana, de Moraes, Josué, Rando, Daniela Gonçales Galasse |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131760/ https://www.ncbi.nlm.nih.gov/pubmed/30214457 http://dx.doi.org/10.1186/s40409-018-0163-x |
Ejemplares similares
-
A QSAR Study for Antileishmanial 2-Phenyl-2,3-dihydrobenzofurans †
por: Bernal, Freddy A., et al.
Publicado: (2023) -
2-Bromo-4-phenyl-1,3-thiazole
por: Bunev, Alexander S., et al.
Publicado: (2014) -
Targeting the Schistosoma mansoni nutritional mechanisms to design new antischistosomal compounds
por: Pavani, Thaís F. A., et al.
Publicado: (2023) -
Synthesis and Antibacterial Assessment of N-[4-(4-substituted phenyl)-1,3-thiazol-2-yl]-1,3,5-triazin-2-amine
por: Gahtori, P., et al.
Publicado: (2009) -
Phenyl N-(1,3-thiazol-2-yl)carbamate
por: Tang, Jian-Guo, et al.
Publicado: (2009)